Eascra Biotech
Boston, MA
Eascra Biotech creates Janus base nanomaterials based on DNA nanotechnology that are highly effective and super biocompatible for articular cartilage, central nervous system disorders, solid tumors, and other chronic conditions. Its three generations of DNA-inspired nanotubes are a low-cost, scalable alternative to existing options. Its Janus nanotechnologies can be tailored to improve the therapeutic efficacy of drug treatments for a variety of chronic conditions and medical needs.
eascrabiotech.comCompany Details
Founded
- 2022
Employees
- Between 2 - 10 employees
Raised
- $2,174,990
Headquarters Location
- Boston, MA
Public
- No
Acquired
- No
CEO
Mari Anne Snow
Founders
- Yupeng ChenMari Anne Snow
Company Collections
These are collections Eascra Biotech is a part of. Click on the collection name to view similar companies.
Eascra Biotech's Industries
Eascra Biotech Headquarters Location
Total Amount Raised: $2,174,990
Eascra Biotech Funding Rounds
Grant
$100,000
Grant Investors
MassVenturesGrant
$274,990
Grant Investors
National Science FoundationGrant
$1,800,000
Grant Investors
NASA
Eascra Biotech Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Eascra Biotech.